Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine.

Eur Clin Respir J · 2015 · PMC4629756 · PMID 26557253

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The overall mortality of the IPF patients in clinical trials has been shown to be low ( 34 , 35 ); therefore, the presented results can be considered as highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.